Jan Swartjes

Title: Innovations by Jan Swartjes in Blood Treatment Technologies

Introduction

Jan Swartjes is a notable inventor based in Tubingen, Germany. He has made significant contributions to the field of medical technology, particularly in blood treatment devices. With a total of two patents to his name, Swartjes has focused on developing innovative solutions to improve patient care.

Latest Patents

One of Swartjes' latest patents is a blood treatment device comprising alkaline phosphatase. This invention is designed to dephosphorylate extracellular adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), and/or lipopolysaccharide (LPS) in the blood of patients. The device is intended for use in an extracorporeal blood circuit and includes a matrix with alkaline phosphatase immobilized on it. This technology aims to treat infections, particularly blood or systemic infections like sepsis, and to address sepsis-associated acute kidney injury (AKI).

Another significant patent by Swartjes is for a device and method for the delivery of a thrombin-activated fibrin sealant. This invention features a dispenser designed for hemostasis, which includes a container for a fibrinogen solution and an activation compartment downstream of the container. The activation compartment contains a functionalized support with an immobilized coagulation factor, preferably thrombin. As the fibrinogen solution is dispensed, it passes through the activation compartment, generating and dispensing polymerizing fibrin as a sealant.

Career Highlights

Jan Swartjes is currently associated with Gambro Lundia AB, a company known for its advancements in medical technology. His work has contributed to the development of innovative medical devices that enhance patient treatment options.

Collaborations

Swartjes has collaborated with notable colleagues, including Markus Storr and Stefanie Votteler. Their combined expertise has likely played a role in the successful development of his patented technologies.

Conclusion

Jan Swartjes is a prominent inventor whose work in blood treatment technologies has the potential to significantly impact patient care. His innovative patents reflect a commitment to advancing medical solutions for critical health issues.